Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
15,033,763
-
Share change
-
+783,594
-
Total reported value
-
$1,376,755,580
-
Put/Call ratio
-
80%
-
Price per share
-
$91.57
-
Number of holders
-
114
-
Value change
-
+$94,249,401
-
Number of buys
-
60
-
Number of sells
-
44
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q2 2016
As of 30 Jun 2016,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,033,763 shares.
The largest 10 holders included
Capital Research Global Investors, FMR LLC, SCOPIA CAPITAL MANAGEMENT LP, PRUDENTIAL PLC, DEERFIELD MANAGEMENT CO, Bank of New York Mellon Corp, Viking Global Investors LP, JANUS CAPITAL MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, and FEDERATED INVESTORS INC /PA/.
This page lists
114
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.